Company Regen BioPharma, Inc. OTC Markets
Equities
RGBPP
US75886M4096
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +48.51% |
|
0.00% | -36.40% |
Business Summary
Number of employees: 1
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Regenerative Medical Applications
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +0.44% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +0.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 24/12/24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 24/12/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 29,338 | 0 | 0 | 99.99 % |
Stock B | 0 | 34 | 0 | 0 | |
Stock C | 1 | 4,114,622 | 4,114,118 ( 99.99 %) | 0 | |
Stock D | 0 | 409,551 | 0 | 0 |
Company contact information
Regen Biopharma, Inc.
4700 Spring Street Suite 304
91942, La Mesa
+619 722 5505
http://www.regenbiopharmainc.com![address Regen BioPharma, Inc.(RGBPP)](https://cdn.zonebourse.com/static/address/120795850.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.13% | 122B | |
+19.65% | 115B | |
+21.22% | 26.64B | |
-23.84% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.28% | 15.49B | |
+63.81% | 14.83B | |
+1.94% | 13.67B |
- Stock Market
- Equities
- RGBP Stock
- RGBPP Stock
- Company Regen BioPharma, Inc.